Latest Articles

Publication Date
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa

Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India

Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com

Published: Sept. 26, 2025, 10:25 a.m.
Endometriosis testing specialist expands reach with adolescent clinic in Manchester - NationalWorld

Endometriosis testing specialist expands reach with adolescent clinic in Manchester NationalWorld

Published: Sept. 26, 2025, 10:19 a.m.
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals - Nature

Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals Nature

Published: Sept. 26, 2025, 10:18 a.m.
Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report - BMC Women's Health

Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report BMC Women's Health

Published: Sept. 26, 2025, 10:06 a.m.
Irish researchers to study ‘medical gaslighting’ in women seeking diagnoses for chronic conditions - Irish Medical Times

Irish researchers to study ‘medical gaslighting’ in women seeking diagnoses for chronic conditions Irish Medical Times

Published: Sept. 26, 2025, 7:31 a.m.
What causes endometriosis? Scientists are closer to finding out : Short Wave - NPR

What causes endometriosis? Scientists are closer to finding out : Short Wave NPR

Published: Sept. 26, 2025, 7 a.m.
Big data analysis reveals miR-874 as a suppressor and therapeutic target in the progression from endometriosis to ovarian cancer.

Published: Sept. 26, 2025, midnight
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.

Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …

Published: Sept. 26, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!